Skip to Main Content

Author Details

Chen Hu
Johns Hopkins University School of Medicine
2009
170
44
PMIDPaper TitleJournal TitlePublished Year
38049229A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2024
36316967The impact of salvage radiotherapy initiation at PSA⿿⿤⿿0.5⿿ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.Prostate2023
37529719Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.Ther Adv Neurol Disord2023
37505106A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.Radiol Imaging Cancer2023
37835523Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer.Cancers (Basel)2023
37460235Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS Trial.Neurology2023
37123604Radiation Protection of Polydatin Against Radon Exposure Injury of Epithelial Cells and Mice.Dose Response2023
37306711Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.Ann Hematol2023
37035880Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials.Stat Med2023
37001764Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy.Int J Radiat Oncol Biol Phys2023
36623978A radiomics model development via the associations with genomics features in predicting axillary lymph node metastasis of breast cancer: a study based on a public database and single-centre verification.Clin Radiol2023
36691798Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort.Mult Scler2023
36831368Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI.Cancers (Basel)2023
36017766Joint inference for competing risks data using multiple endpoints.Biometrics2023
36162136Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor.Cancer Prev Res (Phila)2023
34059508Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.Gut2022
35353808RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells.PLoS Genet2022
35402281Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-Enabled Pancreatic Cancer Radiation Therapy.Front Oncol2022
35642638SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.J Clin Invest2022
35394064Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement.Med Phys2022
36612272Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data.Cancers (Basel)2022
36451132The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.BMC Urol2022
36332624Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma.Cancer Cell2022
36306499Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment.JCO Clin Cancer Inform2022
36193794Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancer.Thorac Cancer2022
36118131Association of Pathologic Complete Response and Long-Term Survival Outcomes Among Patients Treated With Neoadjuvant Chemotherapy or Chemoradiotherapy for NSCLC: A Meta-Analysis.JTO Clin Res Rep2022
36077735Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma.Cancers (Basel)2022
35075200Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations.Sci Rep2022
34861697Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo.Blood Adv2022
35255696Assessing surrogacy using restricted mean survival time ratio for overall survival in non-small cell lung cancer immunotherapy studies.Chin Clin Oncol2022
35129721Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.Ann Surg Oncol2022
35144016Location, Location, Location: What Should be Targeted Beyond Gross Disease for Localized Pancreatic Ductal Adenocarcinoma? Proposal of a Standardized Clinical Tumor Volume for Pancreatic Ductal Adenocarcinoma of the Head: The "Triangle Volume".Pract Radiat Oncol2022
35142085High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapy.Cancer Med2022
35263150Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR).J Clin Oncol2022
35334192Regression trees and ensembles for cumulative incidence functions.Int J Biostat2022
35259416Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer.Radiother Oncol2022
32976776Next-Generation Analytics for Omics Data.Cancer Cell2021
35755402ANALYSIS OF REGRESSION DISCONTINUITY DESIGNS USING CENSORED DATA.J Stat Res2021
33626896Are restricted mean survival time methods especially useful for noninferiority trials?Clin Trials2021
33598430Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients.Front Oncol2021
33760638External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases.JCO Clin Cancer Inform2021
33898083Bone density and fracture risk following SBRT for non-spine bone metastases.J Radiosurg SBRT2021
33587968Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer.Radiother Oncol2021
33555936Longitudinal Trends of Financial Toxicity in Patients With Lung Cancer: A Prospective Cohort Study.JCO Oncol Pract2021
34944813Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.Cancers (Basel)2021
34473547Improving Early Identification of Significant Weight Loss Using Clinical Decision Support System in Lung Cancer Radiation Therapy.JCO Clin Cancer Inform2021
34524050Reply to Quartagno et al.Clin Trials2021
34742270POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.BMC Cancer2021
34323922Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.JAMA Oncol2021
34117863Methylation-eQTL analysis in cancer research.Bioinformatics2021
  • 1 - 50 of 170

Recommended Authors

David C Qian
Winship Cancer Institute of Emory University
Career Start Year 2015
Number of shared co-authors 1
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 9
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 2
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 2
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 15
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 3
Michael Xiang
University of California los angeles
Career Start Year 2007
Number of shared co-authors 15
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 3
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 2
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 8
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Nora Horick
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 4
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 9
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 1
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 3
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 7
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 23
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 9
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 9
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year 1992
Number of shared co-authors 4
Wei Xu
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 0
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2

Collaborators

Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 34
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 29
Han Liang
MD Anderson Cancer Center
Co-authored papers 15
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 12
Ken Chen
University of Texas MD Anderson Cancer Center
Co-authored papers 6
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Co-authored papers 6
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Co-authored papers 6
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 6
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 5
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 5
William F Symmans
Co-authored papers 5
Lajos Pusztai
Co-authored papers 4
Yiling Lu
Co-authored papers 4
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Yuan Yuan
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Minesh P Mehta
Co-authored papers 3
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Curtiland Deville
Johns Hopkins University
Co-authored papers 2
Dalliah M Black
Co-authored papers 2
Huanmei Wu
Temple University College of Public Health
Co-authored papers 2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Min Jin Ha
Co-authored papers 2
Wenbin Liu
Co-authored papers 2
Release 1.2